Agf Investments Inc. Acadia Pharmaceuticals Inc Transaction History

Agf Investments Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $131,414 - $274,949	-10,101 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$20.94 - $27.5 $156,568 - $205,617	-7,477 Reduced 42.54%	10,101 $245,000
Q4 2021 Feb 01, 2022	BUY	$16.79 - $27.09 $107,086 - $172,780	6,378 Added 56.95%	17,578 $410,000
Q3 2021 Nov 10, 2021	BUY	$15.78 - $24.77 $42,037 - $65,987	2,664 Added 31.21%	11,200 $186,000
Q2 2021 Aug 10, 2021	BUY	$19.4 - $27.42 $165,598 - $234,057	8,536 New	8,536 $208,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.